为您找到相关结果约500个

你是不是要搜索 期刊PD-1/CTLA-4双特异性抗体 点击跳转

Functions of CD28, CTLA-4 and PD-1

PD-L1/PD-1 and CTLA-4 Expression in Equine Penile Squamous Cell Carcinomas

Uveal consequences of CTLA-4 and PD-1 inhibition

Soluble CTLA-4 mutants ameliorate immune-related adverse events but preserve efficacy of CTLA-4-and PD-1-targeted immunotherapy

Novel immune checkpoint targets: moving beyond PD-1 and CTLA-4

Combination of CTLA-4 and PD-1 blockers for treatment of cancer

CTLA-4 and PD-1 Ligand Gene Expression in Epithelial Thyroid Cancers

Inhibitory receptors and ligands beyond PD-1, PD-L1 and CTLA-4: breakthroughs or backups

Programmed Cell Death 1 (PD-1) and Cytotoxic T Lymphocyte-Associated Antigen 4 (CTLA-4) in Viral Hepatitis

PD-1 checkpoint blockade alone or combined PD-1 and CTLA-4 blockade as immunotherapy for lung cancer?

Combination immunotherapy using anti-PD-1/PD-L1 plus anti-CTLA-4 antibodies

Immunomodulatory role for MicroRNAs: Regulation of PD-1/PD-L1 and CTLA-4 immune checkpoints expression

Molecular Interactions of Antibody Drugs Targeting PD-1, PD-L1, and CTLA-4 in Immuno-Oncology

Targeting immunosuppressive Ly6C+classical monocytes reverses anti-PD-1/CTLA-4 immunotherapy resistance

Distinct Cellular Mechanisms Underlie Anti-CTLA-4 and Anti-PD-1 Checkpoint Blockade

为您找到相关结果约500个

共500条页码: 1/34页15条/页